Dividends Calendar Earnings Calendar
NERV

NERV | Minerva Neurosciences Inc

Minerva Neurosciences Inc
Category: Consumer goods
  • Industry: Biotechnology

Quick infos

  • Headquarters:   Waltham, Massachusetts, United States

Trade prices

  • Volume:
  • Market Cap: 61.09M
  • Prev closed: 2.29
  • Open: 2.22
  • High: 2.31
  • Low: 2.15
  • 52 week low: 1.81
  • 52 week high: 15.22
  • Dividends:No Dividends

Next ER: November 8, 2021  Before Market Opens



Top Stories (NERV)

    Company Profile

    Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on the development and commercialization of a portfolio of products to treat central nervous system (CNS) diseases. Minerva's portfolio of compounds includes: Roluperidone (MIN-101) in Phase 3 clinical  development for schizophrenia; a potential royalty stream from Seltorexant (MIN-202 or JNJ 42847922), in clinical development for insomnia and major depressive disorder (MDD); and MIN-301, in pre-clinical development for Parkinson's disease. Minerva's common stock is listed on the NASDAQ Global Market under the symbol "NERV."

    Earnings History

    Date EPS / Forecast Revenue / Forecast
    March 14, 2022
    November 8, 2021-0.22 / -0.2172- / 250K
    August 2, 2021-0.25 / -0.174- / 574K
    May 12, 2021-0.21 / 0.332- / 24M
    March 8, 2021-0.17 / -0.1909- / -
    view more

    Historical Data

    DatePriceOpenHighLowVolChangeER
    Nov 19, 2021 1.120 1.150
    1.170
    1.110
    325.49K -5.08%
    Nov 18, 2021 1.180 1.260
    1.260
    1.130
    616.97K -5.6%
    Nov 17, 2021 1.250 1.300
    1.360
    1.250
    622.04K -5.3%
    Nov 16, 2021 1.320 1.300
    1.330
    1.270
    1.81M 2.33%
    Nov 15, 2021 1.290 1.360
    1.360
    1.280
    247.34K -1.53%
    Nov 12, 2021 1.310 1.370
    1.370
    1.290
    244.10K -2.96%
    Nov 11, 2021 1.350 1.380
    1.390
    1.330
    173.81K -1.46%
    Nov 10, 2021 1.370 1.460
    1.490
    1.360
    225.34K -6.16%
    Nov 9, 2021 1.460 1.400
    1.480
    1.390
    253.00K 3.55%
    Nov 8, 2021 1.410 1.380
    1.420
    1.330
    225.77K 4.44%
    view more
    NASDAQ - Nasdaq Stock Market

    More profiles and info about the company

    • Founded:2007
    • Employees:11

    News

    News for (NERV)

    This company doesn't provide a dividend.


    Talk about Minerva Neurosciences Inc below in comments section below.

    Do you think you'll buy? Do you already have active trades now?

    EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
    This profile is based on publicly available information and is intended to be informative in nature.

    Most of the datas are collected by our Data Entry and we aim to be as accurate as humanly possible.




    Other ER on Nov 8, 2021 (Same day)

    znga pypl trip newr coty edit sanm mwa cara lmnd wbt jkhy 


    Jump to (Finance sites)

    Research 


    If you are looking for News & events, Press Release, they are available on their Investors Relationssite.


    Consensus
    BUY 100
    HOLD 0
    SELL 0

    Their Official Profiles 

    LinkedIn

    Support this project

    If you want to help pay for server cost or for improving this tool. You can send it via Paypal.
    More features coming soon :)

    Social Media 




    Recommended Books

    Currency Trading For Dummies
    Buy on Amazon

    Currency Trading For Dummies is a hands-on, user-friendly guide that explains how the foreign exchange (ForEx) market works and how you can become a part of it. Currency trading has many benefits, but it also has fast-changing financial-trading avenues. ForEx markets are always moving. So how do you keep up?